OMRF scientists immunized Alzheimer’s mice with a protein believed to play a key role in the disease-causing process. The mice who received the vaccination showed a significant reduction in the build-up of protein plaques that, when present in the brain for long periods of time, are believed to cause the cell death, memory loss and neurological dysfunction characteristic of Alzheimer’s.
The immunized mice also showed better cognitive performance than control mice that had not received the vaccine.
“These results are extremely exciting,” said Jordan Tang, Ph.D., the OMRF researcher who led the study. “They certainly show that this vaccination approach warrants additional investigation as a therapy for Alzheimer’s disease.”
The new research appears in The Journal of the Federation of American Societies for Experimental Biology.
Tang and his colleagues at OMRF previously had identified the cutting enzyme (known as memapsin 2) that creates the protein fragments believed to be the culprit behind Alzheimer’s. In the current study, researchers used mice that had been genetically engineered to develop symptoms of Alzheimer’s, then immunized the animals with memapsin 2.
“What we saw is that the mice immunized with memapsin 2 developed 35 percent fewer plaques than their non-vaccinated counterparts,” said Tang. “Those immunized mice also performed better than control mice in tests designed to assess their cognitive function.”
Tang’s work with memapsin 2 also has led to the creation of an experimental drug to treat Alzheimer’s disease. That drug, which works by inhibiting the cutting enzyme, began human clinical trials in the summer of 2007.
Tang emphasized that the vaccine approach should be viewed as a supplement to—rather than substitute for—the experimental inhibitor and other treatments currently in development for the illness.
“Alzheimer’s is a complicated, multi-faceted disease,” said the OMRF researcher. “As with illnesses like cancer and heart disease, Alzheimer’s demands that we develop many different approaches to combat it. We cannot rely on a 'one-size-fits-all' strategy, because what works in one patient will not necessarily work in another.”
A vaccination approach—getting the immune system to clean up the plaques—has been considered a promising way to tackle the disease, but its success has been limited. In 2002, for example, the pharmaceutical company Elan halted trials of a different vaccine after 15 patients suffered swelling of the central nervous system.
OMRF President Stephen Prescott, M.D., is hopeful that Tang’s work will avoid the pitfalls that beset Elan’s vaccine. “This vaccination stimulates the immune system more gently than previous Alzheimer’s vaccines, so we are optimistic about its prospects going forward,” he said. “Once again, Dr. Tang has found an innovative way to make inroads against a devastating and poorly understood disease.”
The next step, said Tang, will be to progress the work to the point that it can be tested in humans. “There currently is no effective treatment for Alzheimer’s disease, so we must explore every possible option to find a way to stop it,” he said.
The research was supported, in part, by a grant from the Alzheimer’s Association.
“The Alzheimer’s Association is pleased to provide funding for innovative work such as this to develop possible new therapies for Alzheimer's,” said William Thies, Ph.D., vice president for Medical & Scientific Relations at the Alzheimer’s Association. “It is important to encourage imaginative researchers to test unconventional strategies, as Dr. Tang has done here. We face an overwhelming epidemic of Alzheimer's and dementia if we don't change the current unsatisfactory situation by greatly improving early detection, treatment and prevention.”
Adam Cohen | EurekAlert!
Deep Brain Stimulation Provides Sustained Relief for Severe Depression
19.03.2019 | Universitätsklinikum Freiburg
AI study of risk factors in type 1 diabetes
06.03.2019 | University of Gothenburg
DESY and MPSD scientists create high-order harmonics from solids with controlled polarization states, taking advantage of both crystal symmetry and attosecond electronic dynamics. The newly demonstrated technique might find intriguing applications in petahertz electronics and for spectroscopic studies of novel quantum materials.
The nonlinear process of high-order harmonic generation (HHG) in gases is one of the cornerstones of attosecond science (an attosecond is a billionth of a...
Nano- and microtechnology are promising candidates not only for medical applications such as drug delivery but also for the creation of little robots or flexible integrated sensors. Scientists from the Max Planck Institute for Polymer Research (MPI-P) have created magnetic microparticles, with a newly developed method, that could pave the way for building micro-motors or guiding drugs in the human body to a target, like a tumor. The preparation of such structures as well as their remote-control can be regulated using magnetic fields and therefore can find application in an array of domains.
The magnetic properties of a material control how this material responds to the presence of a magnetic field. Iron oxide is the main component of rust but also...
Due to the special arrangement of its molecules, a new coating made of corn starch is able to repair small scratches by itself through heat: The cross-linking via ring-shaped molecules makes the material mobile, so that it compensates for the scratches and these disappear again.
Superficial micro-scratches on the car body or on other high-gloss surfaces are harmless, but annoying. Especially in the luxury segment such surfaces are...
The Potsdam Echelle Polarimetric and Spectroscopic Instrument (PEPSI) at the Large Binocular Telescope (LBT) in Arizona released its first image of the surface magnetic field of another star. In a paper in the European journal Astronomy & Astrophysics, the PEPSI team presents a Zeeman- Doppler-Image of the surface of the magnetically active star II Pegasi.
A special technique allows astronomers to resolve the surfaces of faraway stars. Those are otherwise only seen as point sources, even in the largest telescopes...
Researchers at Chalmers University of Technology and the University of Gothenburg, Sweden, have proposed a way to create a completely new source of radiation. Ultra-intense light pulses consist of the motion of a single wave and can be described as a tsunami of light. The strong wave can be used to study interactions between matter and light in a unique way. Their research is now published in the scientific journal Physical Review Letters.
"This source of radiation lets us look at reality through a new angle - it is like twisting a mirror and discovering something completely different," says...
11.03.2019 | Event News
01.03.2019 | Event News
28.02.2019 | Event News
22.03.2019 | Life Sciences
22.03.2019 | Life Sciences
22.03.2019 | Information Technology